HIV-1 RNA, Qualitative, TMA [16185]

For Specimen Integrity during Extreme Weather see the “Lockbox Usage in Extreme Weather” document at the top of this page.

HIV1QL

16185

1.6 mL serum

0.8 mL

Plasma collected in a PPT potassium EDTA (white-top) tube, or EDTA (lavender-top) tube

Separate plasma or serum from the cells by centrifugation within 24 hours after
collection.  Transfer the plasma or serum to a plastic screw-cap vial and ship frozen.

Plastic screw-cap vial

Frozen

Room temperature: 72 hours
Refrigerated: 5 days
Frozen: 42 days

⁠⁠⁠⁠⁠⁠⁠Whole blood • Unspun PPT • Frozen Plasma received in plasma preparation tube (in situ) • Frozen serum received in serum separator tube (in situ)

Set up: Tues, Thurs, Sat; Report available: 1-5 days

Not detected

HIV-1 Qualitative is an in vitro nucleic acid amplification test for the qualitative detection of human immunodeficiency virus type 1 (HIV-1) RNA in human serum and plasma by PCR. The test is intended to be used as an aid in diagnosis of HIV-1 infection. Detection of HIV-1 nucleic acid is indicative of HIV-1 infection. The presence of HIV-1 nucleic acid in the plasma or serum of individuals without antibodies to HIV-1 is indicative of acute or primary HIV-1 infection. The HIV-1 Qualitative PCR may also be used as an additional test to confirm the presence of HIV-1 infection in an individual with specimens reactive for HIV-1 antibodies or antigens. The assay may also be used as an aid in the diagnosis of infection with HIV-1 in pediatric subjects and pregnant women. This assay is not intended to be used for monitoring patient status, or for screening donors of blood, plasma, or human cells, tissues, and cellular and tissue-based products (HCT/Ps) for HIV.